Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Oct 10, 2023 12:41pm
72 Views
Post# 35677245

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2,749000 TILRAY SHARES

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:2,749000 TILRAY SHARESThank you very much alleyesonme but it is always a team effort on this board, and the gold star goes to you as you were the one who first found the Market Screener article.

Lets hope things are in fact as they appear in the Form 8 regulatory disclosure, and I agree with you that as Medipharm continues to get its ducks in a row, a greater take over target will be on them.

A poison pill of some kind would be nice to see especially for those loyal shareholders who have stuck this out for so long.
<< Previous
Bullboard Posts
Next >>